The appearance of constitutional symptoms, splenomegaly, PTL increase, RBC increase or cytopenia in patients with CML in MR should lead clinicians to rule out a coexisting Ph-negative MPN and mutations of JAK2, MPL, CALR should be evaluated. This evidence concerns the gene MPL and myeloproliferative neoplasm.